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Abstract
Extracellular vesicles (EVs) are released by nearly all cell types within the human
body and have been found to play important biological roles including cell-to-cell
communication, apoptosis and tissue repair. Lacking cellular machinery, these nano-sized
vesicles carry functional proteins and nucleic acids from their parent cells, providing insight
into biomarkers present in healthy, cancerous and diseased cells. EVs may be isolated from
biofluids such as from blood or urine. Their detection and characterization holds extreme
potential in developing less invasive disease detection and treatment methods.
In this work, we propose use of lithographic techniques to fabricate platforms to
allow for molecular-level characterization by surface-enhanced Raman spectra (SERS). Two
methods of lithography are proposed to probe spectral signatures of individual EVs without
use of labelling agents. SERS spectra are acquired for EVs released from two cell lines,
allowing for determination of the diversity existent within a cell line, and amongst different
cell lines.

Keywords
4-mercaptophenyl boronic acid (4-MPBA), biosensing, electron beam lithography (EBL),
exosome, extracellular vesicle (EV), localized surface plasmon resonance (LSPR),
nanosphere lithography (NSL), Raman spectroscopy, surface enhanced Raman spectroscopy
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Chapter 1

1

General Introduction
The development of nanomaterials and their integration using micro- and

nanoscale fabrication has driven a rapid increase in development of point-of-care
technologies in recent decades.1-4 These applications have yielded a variety of sensing
devices with extreme sensitivity, and have been applied to study a variety of biological,
physical and chemical phenomena with sensing capabilities down to the single molecule
level.5 This thesis seeks to develop and characterize a sensing platform to trap and detect
nanoscale biological materials known as extracellular vesicles. Exosomes and
microvesicles, two categories of extracellular vesicles range in size between 100 nm to 1
micron and are the subjects of very active field of research due to their chemical stability
and relation to disease detection and diagnostics. We propose the use of an advanced
spectroscopic method with high sensitivity and specificity, known as surface-enhanced
Raman spectroscopy to detect and characterize individual extracellular vesicles.

1.1 Overview
Raman spectroscopy has emerged as a powerful optical technique for studying
biological materials such as cells,6 proteins7 and nucleic acids.8, 9 Upon irradiation with
an intense light source, matter will scatter light either elastically (exhibiting no change of
energy), known as Rayleigh scattering, or inelastically known as Raman scattering.
Raman scattering involves a change of energy either towards higher energies (anti-Stokes
Raman scattering) or smaller energies (Stokes scattering).10 The energy changes
associated with the Raman scattering contain information pertaining to the vibrational
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modes of molecules. Inelastic scattering was first reported in the literature in 1928 by
C.V Raman upon questioning the characteristic blue color of water.11 This discovery led
to the birth of a new field, and subsequently to a Nobel Prize awarded to C. V. Raman in
1930. Although Raman spectroscopy became a new tool in the scientist’s toolkit
following its initial discovery, developments within the field were limited for many years
due to the relative weakness of Raman scattering without availability of intense
monochromatic light sources or highly sensitive detectors. The development of lasers,
charge coupled devices (CCD), and the combination of Raman measurements with
optical microscopy have all led to further development of modern Raman instrumentation
that provides spectra with exquisite sensitivity and spatial resolution. The applications
range across many fields such as study of semiconductor materials,12, 13 physical
materials14 and biological samples.9
Further to the general principle of Raman spectroscopy, in 1974, Fleischmann et
al. observed a Raman signal one million times stronger than hypothesized when
obtaining the Raman spectra of pyridine molecules adsorbed to a roughened metal
electrode surface.15 This discovery lead to the concept of surface-enhanced Raman
spectroscopy (SERS). Following Fleischmann’s serendipitous discovery, the physical
principles responsible the SERS enhancement became a field of great interest. In 1977,
Creighton16 and Van Duyne17 proposed the electromagnetic and chemical enhancement
mechanisms for the SERS enhancement that is observed only in conductive surfaces such
as rough metals or other nanostructured conductive materials. Since then, scientists have
probed information on chemical identity,18 composition,18 structure,19 purity20 and
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symmetry21 using SERS, which has now become a well used methodology for research
across a variety of scientific subdisciplines.
With SERS, Raman scattering is typically enhanced by a factor of 102 – 109
enabling the detection of the analytes positioned near a metallic nanostructured surface
with weak laser intensity and/or short acquisition time.22 The large enhancement enabled
by SERS is sufficient to allow for single molecule detection making it a valuable
technique for biomedical applications.23 The enhancement factor allowed by SERS
depends on the shape of the nanostructure, its resonances, and the electric field
enhancement near the surface of the structure.24 For example, a nanoporous coppertitanium film exhibited excellent SERS enhancement up to 107 when functionalized with
Rhodamine 6G, a common Raman reporter dye.22
With the development of nanoscale science and nanofabrication technology, a
variety of nanostructures have been used for SERS applications. For SERS-based studies,
common substrates are nanoparticles on a substrate,25 colloidal nanoparticles,26, 27
metallic films,22 and nanohole arrays encased in a metallic film.28 Typical metals used for
preparation of SERS substrates are silver, gold and copper.28-30 Classically, metallic
nanostructured surfaces displaying surface roughness are utilized for SERS, similar to
Fleischmann’s experiments.31 Since then, a variety of top-down and bottom-up
fabrication techniques have been established for substrate fabrication. Bottom-up
methodology involves self-assembly of individual material building components to
generate larger nanostructures, whereas top-down methodology involves removal of bulk
materials from a substrate to reveal desired nanostructures. Commonly, nanosphere
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lithography is considered a top-down approach whereas electron beam lithography (EBL)
is commonly used as a bottom-up approach.32

1.1.1

Applications of SERS in Biology
SERS is a powerful analytical technique for studying biological materials due to

its non-destructive nature and ability to work in aqueous and dry conditions. As opposed
to fluorescence measurements, Raman spectroscopy does not require staining and may
therefore be used to obtain native molecular and chemical information pertaining to
molecules. Molecular information pertaining to the symmetry and orientation molecules
is useful for applications in polymer and materials sciences,33, 34 biochemistry,35, 36
biosensing,37 and electrochemistry.38, 39 SERS-based biosensing has been exploited to
detect diseases such as Alzheimer’s disease,40, 41 human immunodeficiency virus,42 and
various cancers.43-45 SERS has additionally been used as a tool for studying cellular
adhesion.46 pH sensing,47 glucose sensing,48, 49 and detection of bacteria.50, 51

1.2

Biological SERS Detection Methodologies

1.2.1

Indirect Detection methods
Detection methodologies for biological SERS applications may be grouped into

direct and indirect methods. Indirect methods involve monitoring of a secondary analyte,
known as a “Raman reporter”, which interacts with a species of interest upon
introduction. The interaction of the secondary analyte with the species of interest is
monitored spectroscopically by a change in peak intensity and/or peak position, which
signals a successful binding event or interaction. These changes may be monitored to
reveal quantitative information on the analyte of interest. Secondary analytes commonly
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used for SERS are boronic acid esters,52 aptamers,53 and nucleic acids.54 Additional
secondary analytes include 4-mercapto benzene thiol,55 4-amino benzene thiol,56, 57 and
nile blue.58
Boronic acid esters are also commonly used for SERS applications for saccharide
detection. They form cyclic boronate esters with 1,2 and 1,3- diols, making them great
candidates for detection of saccharides and sugars.59 More recently, boronic acid esters
have been used for biosensing of sugars. For example, 4-mercaptophenyl boronic acid (4MPBA) has been used to sense fructose. Detection of fructose present in urine samples
reported at millimolar concentrations based on peak intensity changes of 4-MPBA. The
symmetry breaking of 4-MPBA upon fructose binding lead to a change in the relative
ratio between the symmetric ring mode at and non-symmetric ring mode, signaling the
successful binding of glucose.60
4-MPBA has also been used for biosensing of glycan distribution across
cancerous and non-cancerous cell lines based on its interaction with 1,2- and 1,3- diols of
saccharides present in glycans.52 Monitoring of the relative intensity of two peaks
corresponding to B-OH stretching and C-C phenyl stretching of the phenyl group of 4MPBA were studied to determine overall glycan distribution and expression on cellular
surfaces. Biosensing capabilities allowed by 4-MPBA allowed for determination of an
elevated glycan distribution in cancerous cell lines when compared to the non-cancerous
cell line.
Aside from commonly studied sugar and glycan detection, boronic acid esters
have been used as reporters to detect biomolecules such as dopamine. For example,
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quantitative detection of dopamine was reported in human cerebrospinal fluids by
functionalization of gold nanoparticles with 3-MPBA.61 No SERS signal detected for the
nanoparticle probes, however an intense SERS signal was gained upon introduction of
dopamine, signaling a successful binding event.

1.2.2

Direct Detection Methods
Incorporation of a secondary analyte for indirect SERS monitoring of biologically

relevant species has proven useful for studies across a wide variety of scientific
subdisciplines. However, methods involving direct monitoring without the use of a
secondary labelling agent are of great interest for clinical applications and for rapid, onsite detection. Such methods typically involve use of metallic nanoparticles or roughened
metallic surfaces for SERS acquisition, and are referred to as direct monitoring methods
since SERS probes are placed in direct contact with the biomolecule(s) of interest.
Use of metallic nanoparticles for direct SERS detection of biological species has
proven useful for virus and disease detection. Gold nanorods have been used to directly
monitor spectral differences of normal red blood cells compared to red blood cells
(RBCs) infected with malaria virus at various stages of disease progression.62 Using
chemometric analysis, peak changes were identified that corresponded to expected
membrane alterations upon infection of cells with the virus. One of these membrane
changes corresponded to a change in the relative ratio of amino acids to cholesterol,
which after infection increased more than 4-fold compared to normal RBCs. Additional
to viruses, cancer biomarkers have also been monitored using direct SERS detection
methodology. Gold and silver nanoparticles were used recently to encapsulate and detect
cytidine in urine, a biomarker indicative of early onset of colon cancer.63 Detection levels
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at millimolar concentrations were reported, thereby confirming that SERS could be used
to monitor cytidine for evaluation of colon cancer risk at early stages.
Chip-based approaches have also been used for direct detection methodologies by
SERS. Immobilization of bacteria onto a glass coverslip, followed by introduction of
charged gold nanoparticles was used recently to differentiate and detect several types of
gram-positive and gram-negative bacteria.64 Direct contact of NPs with the membranes of
bacteria allowed for direct SERS sensing of nucleic acids, membrane proteins and
membrane carbohydrates for each individual strain. Reproducible SERS spectra were
acquired with a good signal-to-noise ratio and with low acquisition times. SERS-active
substrates have been reported for direct SERS sensing of a variety of biological materials.
For example, silver-coated nanohole arrays were utilized to trap biological vesicles
released from an ovarian cancer cell line.31 Capturing of vesicles occurred without the
need for antibodies or other anchoring proteins. Vesicles trapped within the nanoholes
were probed by SERS, allowing for molecular-level characterization of nanometer-sized
biological species.

1.2.3

Scope of Thesis
This thesis is organized into five chapters. Chapter 1 introduces the field of SERS

and outlines current work within this context for biological applications. Chapter 2
focuses on experimental details of this thesis, providing in-depth background information
into the physical, chemical and biological principles underlying this work. Chapter 2 also
provides important information on the clinical relevance of this work. Chapter 3 outlines
nanofabrication techniques to fabricate plasmonically active platforms for SERS and
examines their ability to trap and probe nanoscale materials. Chapter 4 extends this work
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to application-based sciences and presents results of probing spectral signatures from
biological vesicles by SERS. Chapter 5 concludes this thesis with final remarks and
future suggestions.
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Chapter 2

2

Extracellular Vesicles (EVs)
Extracellular vesicles are secreted by nearly all cell types within the body and are

present in nearly all our biofluids. They were previously believed to be junk materials
released from cells but are now widely accepted to play diverse and functional roles
throughout the body. This chapter introduces EVs, outlines their functions and describes
some spectroscopic and biological methods that may be used to validate their presence
and composition.

2.1 History of EVs
In 1946, Chargaff and West unknowingly discovered extracellular vesicles (a
subgroup known as microvesicles) when they observed a precipitate factor present in
platelet-free plasma.1 In 1967, Wolf described extracellular vesicles as ‘platelet dust,’
after discovering what he believed to be lipid ‘junk’ present in a fraction of a plasma
sample following ultracentrifugation.2 Following their serendipitous discovery, scientists
discovered that EVs were anything but dust. They have since been found to play
important roles in the fields of immunology,3,4 cell biology,5,6 biochemistry,7, 8
neuroscience,9,10 and ophthalmology.11,12 The intense interest in EVs has grown largely
throughout the past decade, as shown in Figure 2.1 by the number of publications
accepted to journals across scientific subdisciplines.
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Figure 2.1 - Number of publications retrieved from webofknowledge.com
mentioning ‘extracellular vesicle’ as of June 20, 2018

2.1.1 Classification and Composition of EVs
The umbrella term, ‘extracellular vesicle’ refers to three main types of
vesicles: exosomes, microvesicles and apoptotic bodies. Nomenclature for classification
of EVs has been under considerable debate in recent decades. Previously, EVs were
solely classified based on the type of cell they were released from. For example, prostatecell derived vesicles were classified as prostasomes,13 whereas neuronal vesicles were
classified as synaptic vesicles.14 However, a new classification system extended
classification based on origin to size, allowing for universal comparison across cell lines.
Exosomes (30 nm – 100 nm) originate from the cytoplasmic region of cells and are
exocytosed into the extracellular environment upon fusion of multivesicular bodies
(MVBs) with the plasma membrane of cells. Microvesicles are larger versions of
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exosomes (50 nm – 1000 nm) and are released by membrane blebbing from the cellular
surface. Apoptotic bodies are the largest class of EV (50 - 5000 nm) and are released
during cellular apoptosis. In addition, these three classifications of vesicle separate into
different fractions during ultracentrifugation due to their density differences. EV
classification may occur based on size, density and origin as outlined in Table 1.
Table 1 - Classification of EVs
Type of EV

Exosome

Microvesicle

Approximate

Density

Detection/

Origin/ Location of

Size (nm)

(g/mL)

Characterization

Release

30 – 100

1.13 –

TEM, WB, FC,

Exocytosis of

1.19

MS

multivesicular bodies

1.03 –

FC, SEM, TEM

Plasma membrane

15, 18, 19

FC, SEM, TEM

Plasma membrane or

15, 20, 21

50 – 1000

Reference

15, 16, 17

1.08

Apoptotic
Body

50 - 5000

1.16 –
1.28

endoplasmic
reticulum during
apoptosis (cell death)

EVs have been found to play diverse and important roles in delivery of cargoes to
target cells. These cargoes include functional proteins, growth factors, nucleic acids and
lipids.22 Their roles include intercellular communication,23 signal transduction,9, 10 T-cell
stimulation,4, 24 cancer metastasis25 and apoptosis.26 Due to their release from cells into
their microenvironment within the human body, EVs may be isolated from biological
fluids such as tears,27 urine,28 blood,29,30 and cerebrospinal fluid.31 A given cohort of EVs
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released from a single parent cell may vary widely in composition and location of
biomarkers. Study of their composition has previously been reported by fluorescence
microscopy, scanning electron microscopy (SEM), transmission electron microscopy
(TEM).32 mass spectroscopy(MS),33 flow cytometry (FC),15 western blotting (WB)34,35
and atomic force microscopy (AFM).36

2.1.2 Methods of Isolating EVs
Ongoing studies seek to understand the modes of action as well as diverse
functional roles of EVs. This information is necessary to better understand disease
progression and their link to biomarker presence and distribution for a wide variety of
diseases. A major challenge thus far in EV research is the lack of standardization in
isolation of EVs. Advances have been noted in isolation techniques involving
ultracentrifugation, differential centrifugation, microfluidics, filtration and
chromatography. This section will focus mainly on isolation of EVs through
ultracentrifugation and filtration.
Ultracentrifugation (UC) is considered the gold standard of EV isolation. It is the
most common method used has been reported to isolate EVs of varying size, density and
origin, including from bodily fluids and conditioned cell culture media. The technique
requires numerous centrifugation steps to isolate EVs from other biological matter such
as dead cells and proteins. UC protocol typically begins with a low-speed centrifugation
step, such as 300 g for 10 minutes to remove dead cells and larger apoptotic body debris.
The proceeding steps vary amongst research groups, however protocols increase speeds
in subsequent steps, between 1000 g to 20,000 g to remove larger protein debris and
larger vesicles.37 The final centrifugation step involves a spin at 100,000 g to precipitate
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EVs to the bottom of the vial, after which supernatant is removed and the EV isolate is
resuspended in phosphate buffered saline, or water in some cases.38 The technique has
been successful at isolating exosomes and microvesicles, however apoptotic bodies have
been reported less commonly in the literature, especially upon resuspension with water
rather than buffer.
Though UC is a gold-standard technique for isolation of EVs, it suffers from long
isolation times, often requiring 4 – 6 hours for complete. In addition, it is difficult to
optimize isolation protocols due to the large variety in sample compositions from various
biofluids or cell cultures. Previous literature has also reported loss of important exosomal
proteins and RNAs following UC, indicating loss of important biomarkers for study of
disease progression and diagnosis.39, 40
Filtration techniques are often reliant on centrifugation steps to remove dead cells
and debris and may minimize time compared to UC. Following initial centrifugation,
filters or membranes may be used to sort EVs from remaining media or biofluids. For
example, Campoy et al. successfully isolated vesicles from uterine cells for study of
endometrial disorders by incorporating a 200-nm filter following a 10,000 g
centrifugation for 30 minutes.41 Applying this method, the group concluded successful
exosomal isolation by SEM and immunoblotting. Filtration through chromatography
columns has also previously been reported following centrifugation steps.42 Although
filtration techniques have proven successful in isolation of EVs, they are still reliant on
centrifugation. In addition, pores and membranes may become clogged during isolation,
meaning re-use of filters is highly discouraged.
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Specificity in isolation of EVs based on biomarkers may be achieved using
magnetic beads coated antibodies specific to antigen present on the surface of EVs, or
antibody coated microfluidic devices.41 However, complete isolation of EVs from other
biomaterials remains as a challenge since origin of samples varies widely.

2.1.3 EVs as Human Liquid Biopsies
In past years, definitive determination of disease diagnosis occurred mainly
through tissue biopsies. Through surgical procedures, a suspected sample would be
removed for biopsy through microscopic and analytical means. Tissue biopsies provide
useful information to the clinician and patient, however the means of obtaining such
samples are often time consuming, invasive, costly and risky to the patient. Additionally,
tissue biopsies mainly provide site-specific information, and do not allow for
differentiation of additional diseases that may be present at locations in a given body or
system.
Movement towards liquid biopsies reduces many of the drawbacks of tissue
biopsies. Liquid biopsies are acquired by collection of blood, urine, tears or saliva. Their
modes of collection are less invasive compared to tissue extraction as they are collected
by needle extraction (blood collection), or by simple collection (urine and tear
collection). These methods minimize sample acquisition time, harm to the patient and
provide additional insight into overall human health since they carry DNA, platelets and
microparticles released from other effector areas of the body. The biofluids undergo
sample preparation protocols to isolate for vesicles, DNA, platelets and other materials of
interest. These biopsies allow for molecular analyses very similar to those allowed by
tissue samples while providing many benefits to the patient.
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Extracellular vesicles, specifically exosomes have been studied in great depth due
to their small size and great stability in liquid environments. The lipid bilayer
surrounding exosomes protects the internal cargo from degradation allowing for study of
their internal contents.43 Additionally, the internal and external biomarkers reflect those
of the cell of their origin, providing a means of studying cell biology while eliminating
complex cellular machinery such as a nucleus or golgi apparatus, which is exceptionally
valuable for spectroscopic studies.

2.1.4 Spectroscopic Studies of EVs
Study of EVs by vibrational spectroscopy allows for study of cellular biomarkers
without bulky cellular machinery. In human health studies, analysis of biomarkers
present internally and externally in EVs may provide information on stage and degree of
disease progression. This information has been probed using Raman,44 SERS,23, 45, 46 and
Fourier-transform infrared spectroscopy (FT-IR).47
Through analysis of the spectroscopic signature of EVs derived from cancerous
and non-cancerous origins, it may also be possible to generate a library spectroscopic
peaks outlining the variation and common cargoes among cell lines. For example, when
comparing cancerous and non-cancerous lines of EVs, some expected conserved
spectroscopic peaks (listed peaks are SERS peaks) may be chain C-C stretches in lipids
from the phospholipid bilayer (700 cm-1), CH2 and CH3 deformations from proteins and
lipids (1450 cm-1), C=C stretches in lipids (1651 cm-1), and amide II vibrations in
proteins (1480-1575 cm-1). In contrast, peaks corresponding to nucleic acids and proteins
such as C-C stretching from proline and valine (930-940 cm-1) and asymmetric phosphate
stretching (1245 cm-1) would be expected to vary.
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2.2 Principles of Surface-Enhanced Spectroscopies
2.2.1 Plasmon Resonances in Metal
Metallic materials consist of charges (free electrons) that may be placed into
motion by coupling of an oscillating electromagnetic field polarized in a defined
direction. This phenomenon is defined within the field of plasmonics, which aims to
control the coupling of an electromagnetic field with the free electrons in the conduction
band of a metals. Plasmons are exploited widely in spectroscopy, in a subfield known as
molecular plasmonics.48 Many studies in molecular plasmonics utilize metallic
nanostructures to exploit the local electromagnetic enhancement near the surface of the
conductive surface or metal. Some of these fields are surface-enhanced Raman
spectroscopy (SERS), tip-enhanced Raman spectroscopy, surface-enhanced fluorescence,
surface enhanced infrared absorption.

2.2.2 Surface Plasmon Polaritons (SPP)
A surface plasmon polariton (SPP) is defined as a collective fluctuation in
electronic density at the interface of a metal and a dielectric. The oscillation frequency of
free electrons is dependent on the type of metal and the surrounding dielectric medium.
Additional factors such as the size of the metallic structure, shape of metallic structure
and the distance between adjacent metallic structures must also be taken into
consideration. Surface plasmon waves are tightly confined to the interface between a
metal and a dielectric. The intensity of a SP decays exponentially away from the surface.
The decay length (i.e. the distance between maximum and minimum field) into the
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dielectric medium may be estimated by λ/2n where n is the refractive index of the
dielectric.49

z

z

Dielectric

~λ/2n

- - -

+++

x

Metal
Figure 2.2 - (a) Schematic of the charge distribution and local electric field
associated with surface plasmons; (b) The strength of the SP decays exponentially
with increasing distance from the metal and dielectric

2.2.3 Localized Surface Plasmon Resonance
A condition known as surface plasmon resonance occurs when the frequency of
incoming light exactly matches that of the frequency of oscillation of surface plasmons.
In the case where a surface plasmon interacts with a nanostructure smaller than the
wavelength of incident light, the surface plasmon becomes confined to the nanostructure,
generating a localized surface plasmon resonance (LSPR). In LSPR, the free electrons in
the metal oscillate with respect to the induced electric field causing the momentum and
wavevector of the nanostructure to change.

x
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Figure 2.3 – Localized surface plasmon resonance of a metallic nanoparticle
Bulk surface plasmons are differentiated from localized plasmons when working
with nanoparticles or nanostructures on the sub-wavelength size scale. LSPR modes are
dependent on the metal type as well as the size and shape of the structure.50 The
localization of an incident electromagnetic field near the surface of metallic
nanostructures is the basis of many surface-enhanced techniques.

2.2.4 Raman Spectroscopy
Raman spectroscopy is a spectroscopic technique used to observe vibrational
modes of molecules that compose a material or a biomaterial. It is a label-free technique
offering molecular information from inelastically scattered light. The interaction and
scattering of light off a molecule or biomolecule of interest provides information on the
molecular composition of the system and, when used in conjunction with polarized
measurements, can lead to the determination of molecular orientation at surfaces Raman
spectroscopy is a powerful technique used to study biological and chemical systems, and
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has also been used in the literature to analyze commonalities and differences amongst
extracellular vesicles from cancerous and non-cancerous origins.51, 52
When light impinges onto a molecule or particle of interest, a majority of the light
is elastically scattered. This is the most common form of scattering, known as Rayleigh
scattering. Rayleigh scattering occurs when scattered light is emitted at the same
frequency (v0) as the incident light. 1 in every 108 photons of incident light scatters
inelastically by emitting with a higher or lower frequency compared to the incident
radiation. This shift of energy is known as a Raman shift. Lower energy, or higher
wavelength photons are known as Stokes-shifted photons, whereas higher energy and
lower wavelength photons are known as anti-Stokes shifted photons.

Energy

First Virtual State

v2
v1
v0
Rayleigh Scattering
Elastic

Raman Scattering
Inelastic
Stokes Shifted

Vibrational Levels

Raman Scattering
Inelastic
Anti-Stokes Shifted

Figure 2.4 - Illustration of the various elastic and inelastic scattering paths an
emitted photon may undergo following interaction with a molecule of interest
The various scattering paths a photon may take upon interaction with a molecule
of interest are outlined in Figure 2.5, where v0, v1 and v2 indicate various vibrational
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states of a molecule. Elastic transitions with no net change in energy (such as v0 to v0
transitions) indicate Rayleigh transitions. Inelastic transitions resulting in photons of
higher wavelength (v1 to v0) or lower wavelength (v0 to v2) indicate Raman-active
transitions. Stokes-shifted photons occur more frequently than anti-Stokes shifted
photons due to the probability distribution of molecules occupying excited and ground
state vibrational modes at any temperature, modelled by the Boltzmann distribution
curve.53 At room temperature, most molecules exist in their ground energy state while
only a small fraction exist in an excited vibrational or rotational state.
Although Raman spectroscopy is a well-adapted technique for biological and
chemical studies, it has an intrinsic weak sensitivity due to the poor scattering cross
section of materials. Fortunately, the Raman signal may be enhanced by using surfaceenhanced Raman spectroscopy (SERS) techniques.

2.3 Surface-Enhanced Raman Spectroscopy (SERS)
2.3.1 Electromagnetic Mechanism of SERS
Two mechanisms, the chemical and electromagnetic mechanisms are responsible
for the SERS enhancement. The electromagnetic mechanism of SERS is a direct result of
the localized surface plasmon resonance (LSPR) of metallic nanoparticles. Upon
interaction with the oscillating electromagnetic field of light, the free electrons in the
conduction band of a metallic nanostructure become polarized and generate plasmons in
the electron cloud of the metal.50 At specific frequencies, the oscillation of the metallic
nanostructure will be in resonance with the frequency of the incident light, generating a
LSPR oscillation. Through control of the size, shape, type of metal and the local
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dielectric environment of the metallic NPs, one can fine-tune the resonance condition,
location and strength of the LSPR from visible to near-infrared ranges. The enhancement
factor allowed by the electromagnetic mechanism may be approximately quantified using
equation (1):
E= |E(w)|2 |E(w’)|2

(1)

Where E is the enhancement factor, E(w) is the local electric-field enhancement factor at
the incident frequency, w, and E(w’) is the Stokes-shifted enhancement factor at
frequency w’. E is often estimated by assuming E(w) and E(w’) are the same, leading to
an overall enhancement factor of E(w)4.54
To demonstrate the enhancement of the Raman signal by SERS, experimental
Raman and SERS spectra of malachite green (MG) are shown below (Figure 2.5).

Figure 2.5 – SERS (red) and Raman (blue) spectra of malachite green
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The enhancement allowed by the chemical and electromagnetic enhancement
mechanisms of SERS is visibly considerable. The characteristic Raman peaks of MG
were comparable to the literature. For example, the N-C bonding and C-C stretching
vibrations were observed at 1617 cm-1. Additionally, the bands at 1173 and 1294 cm-1 are
assigned to aromatic C-H bending vibrations.55 The SERS spectrum was obtained by
dilution of MG powder to 1 mM in ethanol and placement onto a SERS-active substrate
prepared by lithography. The Raman spectrum was obtained by placement of bulk MG
powder onto a glass coverslip.

2.3.2 Chemical Enhancement Mechanism of SERS
The chemical enhancement (CE) mechanism is still an active area of study and is
not yet completely understood. It is thought to occur due to formation of a bond between
an adsorbed molecule and a metal. Three distinct phenomena, known as (1) chargetransfer chemical enhancement, (2) resonant Raman enhancement and the (3) nonresonant Raman enhancement mechanisms have been proposed, which work in tandem to
generate the effect.56

2.4 Preparation of Plasmonic Platforms by Nanosphere
Lithography
A common method for fabricating semi-reproducible plasmonic substrates for
collection of SERS spectra is by nanosphere lithography (NSL). NSL is a bench-top
technique reliant on the self-assembly of nanoparticles in hexagonally arranged arrays.
Following self-assembly on a substrate such as quartz, glass or silicon, metal is deposited
and nanoparticles are gently removed by sonication revealing triangular nanostructures
that are SERS active. These structures have previously been fabricated by members of the

26

Lagugné-Labarthet research group and have been reported in the literature for analyte
detection57 and mapping of cancerous biomarkers in different cell lines.58

Figure 2.6 – Schematic of NSL fabrication, with top and side views
NSL offers the ability to fabricate large SERS-active domains several microns in
size. In some cases, areas of coverage have also been reported as centimeters in size.59
However, nanosphere lithography suffers from low reproducibility and homogeneity, and
offers limited variations of structures that may be fabricated.19 Figure 2.7 outlines
structures fabricated by NSL of 1.00 µm polystyrene microspheres by SEM. Figures 2.7
(A, B) illustrate desired nanostructures with well-defined tips at triangle apexes. The
sharp apices of nanotriangles have been characterized previously to generate the
maximum SERS enhancement.60 Challenges in achieving uniformity of the
nanostructures is highlighted in Figure 2.7 C). In the right-half of this image, the
polystyrene distributed into a monolayer formation whereas on the left-half of this image,
a bilayer of polystyrene assembled. Lift-off of the bilayer of PS revealed nanostructures
that are non-uniform in size, shape and spacing.
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Figure 2.7 - SEM images of nanostructures prepared by NSL; A, B) Top view of
nanostructures following lift-off; C) Boundary between a bilayered area and
monolayered area following lift-off of nanospheres
Classic structures generated by NSL are the nanoprisms. Other nanostructures fabricated
by NSL are nanopyramids,61 film-over-nanosphere,62 Moire patterns,63 nanohole arrays,63
nanocrescents64 and nanobowls.65

2.4.1 Preparation of Plasmonic Platforms by Electron Beam
Lithography
To overcome many of the challenges of NSL, electron beam lithography (EBL) is
considered a competitive technique. It offers many benefits over NSL namely precise
control over the sizes and shapes of patterns for fabrication of plasmonically active
substrates. It is also highly reproducible compared to NSL. EBL typically employs a
scanning electron microscope, and an electron beam that is precisely scanned across a
photoresist to generate a pattern. Photoresists are either ‘positive’, or ‘negative’, meaning
areas exposed to the electron beam will either become more or less soluble when exposed
to a developing solution. Positive resists undergo bond breaking in areas exposed to the
electron beam, therefore producing a pattern that is the same as the pattern outlined by
the electron beam (positive image), whereas negative resists undergo bond-making in
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exposed areas, producing the reverse (negative image) as the pattern outlined by the
electron beam. Following electron irradiation, exposed areas in a positive resist dissolve
in developing solution (generally an organic solvent) whereas exposed areas in the
negative resist are maintained. Incorporation of metals such as gold and silver may be
deposited to allow for propagation of plasmons and SERS capabilities.

Figure 2.8 - Schematic illustration of electron beam lithography process performed
on a positive and negative resist.66
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2.4.2 Characterization of Plasmonic Platforms
To characterize plasmonic platforms, the absorption spectra are typically acquired
to determine the optimal wavelengths of LSPR excitation. The LSPR excitation
wavelength maximum (λ max) is sensitive to a variety of factors including the dielectric
constant of the metal, the refractive index as well as the structure and shape of the
metallic nanostructures. Therefore, any changes in metal type, thickness, or substrate
should lead to acquisition of an absorption spectra for characterization of λ max.

Figure 2.9 – Schematic of absorption spectra setup enabling the measurement of
plasmon resonances of the nanostructured surfaces over a surface limited to a few
tens of microns.
Figure 2.8 illustrates a schematic of the apparatus used to obtain an absorption
spectrum. The area required to obtain an absorption spectrum is typically 40 – 100
microns in diameter. The home-build setup involves use of a white light source (halogen
lamp), which is conducted through an optical fiber (100 µm diameter) to a series of
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objectives to reduce the size of the probe beam yet keeping it parallel. These objectives
lead the transmitted light to a spectrometer and ultimately to a charge-coupled detector.
This allows for measurement of the intensity of light upon reaching the spectrometer. The
light transmitted is measured as a function of incident wavelength, allowing calculation
of the ratio of transmitted intensity (I) versus initial intensity (I0) and expressed in units
of absorbance (abs=-log(I/I0).

2.5 Summary
This chapter outlines the biological makeup and clinical relevance of extracellular
vesicles. In addition, the physical principles underlying lithographic techniques proposed
for the characterization of EVs are highlighted. Lithographic techniques may be used to
fabricate nanostructures compatible with surface-enhanced Raman spectroscopy, a
technique based off the inelastic scattering of light. The low scattering cross-section of
inelastically scattered light may be enhanced within plasmonic fields generated at the
surface of a noble metal upon illumination with a monochromatic laser source coupled
with the resonant wavelength(s) of the nanostructures. This provides the basis of surfaceenhanced techniques and allows for detection of analytes down to the single-molecule
level. The mechanisms responsible for this enhancement, known as the chemical and
electromagnetic mechanisms are also discussed in detail.
Fabrication of metallic platforms prepared by lithography are proposed for study
of biological nanomaterials known as extracellular vesicles. Two lithographic techniques,
nanosphere lithography and electron beam lithography are discussed in this realm. NSL is
a well-characterized technique for fabrication of large areas of nanostructures and is
proposed for probing of the bulk SERS spectral signatures of EVs. Electron beam
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lithography is further proposed for controlled fabrication of nanostructures and probing
of individual spectral signatures of EVs. This work ultimately seeks to apply wellcharacterized nanofabrication techniques to study a novel biological application in a
promising field.
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Chapter 3
Fabrication and Characterization of Plasmonic
Platforms

3

This chapter explores the fabrication of plasmonic platforms by nanosphere
lithography and electron beam lithography. The materials and methods used to fabricate
and characterize these platforms are described in detail. The use of plasmonic platforms
is presented within the scope of their desired application, to study biological vesicles.

3.1 Introduction
Advances in nanofabrication have allowed for fabrication of nanostructures with a
high degree of control over the size, the shape, the geometry and the chemical properties
of the materials. As such, several lithographic methods have been developed to fabricate
nanostructures. These methods are typically classified into two groups, namely top-down
or bottom-up fabrication.1 Top-down approaches in nanofabrication such as electron
beam lithography aim to carve large-scale materials to micro- and nano-size features
using lithography or focused ion-beam methods.2-4 These approaches have proven
successful in producing features less than tens of nanometers in size with high precision
and resolution due to advances in photoresist technologies. In contrast, bottom-up
processes such as wet chemical synthesis or nanosphere lithography rely on increasing
the size of a primary building block to generate ordered nanomaterials on a larger size
scale.5-7
Metallic nanostructures have been studied for a wide variety of applications using
surface plasmon resonance (SPR),8, 9 extraordinary optical transmission (EOT),10, 11
surface-enhanced infrared absorption spectroscopy (SEIRA)12-14 and surface-enhanced
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Raman spectroscopy (SERS).15-18 One particularly interesting subclass of nanostructure
previously characterized by the aforementioned technologies is nanohole arrays (NHAs).
NHAs have been fabricated by a variety of methodologies. One commonly reported
method of fabricationg NHAs is based on self-assembly of polystyrene spheres followed
by an etching process, metal deposition and subsequent lift-off of nanospheres.19, 20 This
methodology is successful in generating areas of nanohole arrays, with nanowells
corresponding to one dimension in the areas where nanospheres were originally placed.21
However, the self-assembly of polystyrene often leads to defective areas and allows for
minimal control over the spacing and sizes of individual nanowells. Therefore,
methodologies such as focused ion beam lithography,22, 23 interference lithography,19, 24
and electron beam lithography25, 26 are typically preferred to increase control over sizing
and spacing.
A significant advantage provided by nanohole arrays arises from their ability to
trap and probe materials in confined nanowells. Fabrication of nanohole arrays by
interference lithography has been reported in the literature previously for detection and
trapping of biological proteins.19 For example, when a protein was introduced into
nanowells fabricated by laser interference lithography, optical transmission images
revealed confinement of proteins to the nanowell areas.19 Channels filled with trapped
protein(s) appeared darker in colour upon illumination, whereas channels free of protein
would appear bright under transmissive light settings. Successful trapping of proteins was
therefore achieved and validated. Laser interference lithography is a great technique for
fabricating nanostructures, however it is limited by the resolution of the light source,
which in this case was a UV source. Nanostructures are therefore limited by size due to
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the resolution of the light source. In this case, structures may be resolved to 200 nm and
larger. In cases where features less than 200 nm are desirable, an electron beam source
may be employed to generate high resolution nanostructures down to ~ 50 nm in size.
Recently, plasmonic nanohole arrays have been incorporated into chip-based
sensing for detection of biomaterials. For example, integration of NHAs fabricated by
UV-lithography with an adjustable microfluidic cell module have been reported for
direct, real-time detection of a growth factor released from live under controlled cell
culture conditions.27 Chip-based devices with integrated nanohole arrays hold great
potential in point-of-care diagnostic testing for human health studies. The work presented
throughout this chapter aims to fabricate NHAs in a reproducible manner to probe
microvesicles released by cells.

3.2

Experimental

3.2.1

Materials for Nanosphere Lithography
Cover slips were obtained from VWR International (22 mm x 22 mm x 0.15 mm)

and subjected to acid/base cleaning to yield a pristine surface onto which are formed NSL
patterns. Coverslips were suspended in acetone (Sigma Aldrich), sonicated for 5 minutes
and gently rinsed with ultrapure water. They were subsequently sonicated in a solution of
Nochromix® (Godax Laboratories Inc., Maryland U.S) and sulphuric acid for 20
minutes. After rinsing with milli-Q water (18.2 MΩ.cm), they were sonicated in a 1:1:5
solution of ammonium hydroxide: hydrogen peroxide: milli-Q water for 60 minutes. NSL
was adapted from a previously outlined protocol.28 A 1 cm diameter O-ring was utilized
with a 1:25 v/v ratio of 1 μm polystyrene microspheres to water (10% w/w polystyrene,
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ThermoFisher Scientific, California, U.S.). 20 μL of the polystyrene mixture was drop
casted into the O-ring and allowed to dry for 12 hours. Monolayer coverage was verified
optically, and the substrates were subsequently coated with a 3-nm adhesion layer of
titanium and 30 nm of gold. Lift-off of polystyrene spheres was performed in acetone
(Sigma Aldrich) with mild sonication for 10 – 30 seconds.

3.2.2
3.2.2.1

Materials for Electron Beam Lithography
Polymethymetacrylate (PMMA) Nanohole Arrays

Microscope coverslips were subjected to reactive O2 plasma for 10 minutes. A
positive resist, 495-PMMA-A4 (Microchem, Westborough, MA) was spin coated onto
the substrate surface at 3000 rpm corresponding to a thickness of 1800 Å, respectively.23
Substrates were baked for 90 seconds at 180 °C. Aquasave® conductive polymer
(Mitsubishi Rayon Co.) was spin coated onto the PMMA surface as a conductive layer
and subsequently baked at 110 °C for 2 minutes. Electron-beam lithography was
performed using a LEO 1530 SEM microscope with electron beam capabilities. Patterns
of arrays were designed with varying sizes (0.1 - 1.0 μm, with a 0.1 μm step in between
sizes) and varying shapes (circle and square) using a CAD software (NPGS), and all
patches of patterns measured 50 μm x 50 μm2. A standard procedure using a 1:3 solution
of methyl-isobutyl ketone and isopropanol allowed for development of arrays and
removal of the resist that was exposed to the electron beam.

3.2.2.2

Metallic Nanohole Arrays

Microscope coverslips were subjected to reactive O2 plasma for 10 minutes, after
which a negative resist, Ma-N 2405 (Microchem, Westborough, MA) was spin coated
onto the substrate at a spin speed of 3000 rpm, corresponding to a thickness of
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approximately 6300 Å, and baked for 90 seconds at 90 °C. AquaSAVE conductive
polymer (Sigma-Aldrich) was spin coated at 3000 rpm as a conductive layer and
subsequently baked at 90 °C for 45 seconds. Electron-beam lithography was performed
using a LEO 1530 SEM microscope with electron beam capabilities. Patterns of arrays
were fabricated of varying sizes (0.1 - 1.0 μm, with a 0.1 μm step in between sizes) and
varying shapes (circle, triangles and square) using a CADsoftware(NPGS), and all
patches of patterns measured 50 μm x 50 μm2. Following lithography, samples were
developed in MF-319 developer (MicroChem, Westborough, MA) for 30 - 45 seconds.
Samples were subjected to a 30-second O2 plasma descum process to remove residual
resist surrounding nanopillars. A 3-nm adhesion layer of titanium was then deposited
followed by a 30-nm layer of gold by electron beam evaporation (Angstrom
Engineering). Lift-off was allowed by exposure to remover-PG, a common photoresist
remover heated to 80 °C (MicroChem, Westborough, MA) for 90 minutes to two hours,
depending on the sample. Samples were subjected to a 1:3 solution of methyl isobutyl
ketone and isopropanol to remove remaining remover-PG. Samples were then subjected
to Nanostrip, a stabilized formulation of sulfuric acid and hydrogen peroxide compounds
often used for removal of positive and negative photoresists (Cyantek, California, U.S.A)
heated to 80 °C for 30 minutes and placed in water for 15 minutes to remove remaining
nanostrip. Lastly, samples were subjected to O2 plasma for 5 minutes to remove
remaining resist from inside metallized nanoholes.

3.2.3

Raman and Surface-Enhanced Raman Spectroscopy
A LabRAM HR (Horiba Scientific, NJ, USA) spectrometer was utilized for

Raman and SERS spectroscopy. The spectrometer was equipped with a liquid nitrogen
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equipped charge-coupled detector (CCD), and the excitation source was a helium-neon
laser with a wavelength of 632.8 nm. A 100 × objective (N.A 0.9) was used to collect
backscattered light. Laser power was set to ~ 0.5 mW and acquisition time varied
between 20 – 200 s depending on the sample. A confocal pinhole of 200 µm and grating
of 600 grooves /mm were used for these measurements.

3.2.4

Fluorescence Imaging
Fluorescence imaging was performed with a Zeiss LSM 510 META Multiphoton

Confocal Laser Scanning Microscope. A Zeiss 63 × (N.A. 0.75) air objective as well as a
632.8 nm He-Ne Laser were employed.

3.2.5

Functionalization of Nanohole Arrays
Samples were functionalized for 24 hours in a 10-3 M solution of 4-MPBA (4-

mercaptophenylboronic acid) in ethanol for preliminary testing. A helium neon laser (λ =
632.8 nm) was used as the excitation source, and a 100 × (NA = 0.9) objective was used
to collect back-scattered light. A mapping stage was employed to map the surface
surrounding individual nanoholes measuring 0.9 μm in diameter for both square and
circular shapes, and acquisition time was 5 s per pixel.

3.3

Results and Discussion

3.3.1

Characterization of Platforms Prepared by Nanosphere
Lithography
Several methods were tested to prepare NSL platforms such as drop-casting, air-

water interface or spin-coating. The O-ring method was selected due to its facile
implementation and the desire to improve the method by manipulation of dilution ratio.28
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Figure 3.1 outlines the O-ring method, highlighting the placement of polystyrene solution
inside a 1-cm diameter O-ring and the subsequent self-assembly of polystyrene spheres (1
μm diameter, 10% w/w, ThermoFisher Scientific, California, U.S.) following 12 hours of
drying time.

Figure 3.1 – Photographs of the O-ring method of NSL (A) prior to drying and (B)
after 12 hours of drying time, prepared with 1 μm diameter polystyrene spheres.
The dilution ratio of 1 μm diameter polystyrene spheres to milli-Q water was
initially varied between 1:15, 1:20, 1:25, and 1:50. The best ratio to fabricate the larger
areas of spheres monolayer was determined to be 1:25 by optical assessment of
monolayer packing. This ratio lead to well-packed and high-density monolayered areas of
polystyrene spheres. The characterization of the resulting NSL substrates were done
using by scanning electron microscopy (SEM) and UV-Vis spectroscopy.
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Figure 3.2 – Characterization of NSL nanostructures fabricated using 1-micron
spheres by (A) SEM (B) absorption spectra.
As illustrated in Figure 3.2 A), areas of packed polystyrene spheres allow for
fabrication of regular nanostructures (nanoprisms) with sharp, well defined apices.
Previous research on nanoprisms prepared by NSL has demonstrated confinement of the
EM field occurs at apices, accounting for most of the plasmonic enhancement for SERSbased applications.29 To obtain the most intense SERS enhancement from the NSL
substrate, it is important to match the wavelength of the incident laser with the plasmon
wavelength of the platform. Therefore, the absorption spectra of a NSL substrate is
shown in in Figure 3.2 B). From this graph, the LSPR frequency appears to lie between
630 - 650 cm-1, presenting similar results to those previously reported in the literature.30
Matching of the incoming laser source within this range will allow for the best SERS
signal.
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3.3.2

Preparation of Plasmonic Platforms by Electron Beam
Lithography
To overcome many of the challenges of NSL such as the presence of defects,

electron beam lithography (EBL) is a great alternative. In particular, it allows for control
over shapes, sizing and spacing of nanostructures and provides excellent
reproducibility.31 EBL employs the electron beam of a scanning electron microscope to
scan the surface of a photoresist along defined sets of spatial coordinates. Photoresists
vary between positive or negative types.32 Incorporation of metals such as gold and silver
may be deposited following development to allow for propagation of plasmons and SERS
capabilities.
In this project, nanohole arrays were fabricated with both, positive and negative
resists to ultimately test the ability to trap and probe nanoscale materials. The positive
resist was non-metallized and was solely fabricated for trapping of nanoscale materials,
whereas the negative resist was fabricated with a different protocol and metallized,
allowing for SERS acquisition of trapped nanomaterials. Circular and square nanowells
were fabricated with varying size. The size ranged between 0.1 – 1 μm, with a 0.1 μm
step/increase in size between adjacent patterns, with the same sizes, shapes and
parameters for both resist forms. Fig. 3.3 displays dark-field images of both types of
fabricated arrays, obtained with a Zeiss Axioskop2 MAT microscope.
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Figure 3.3 - (A) NHA fabricated with a positive resist for assessment of trapping
abilities of NHAs; (B) Close-up of positive resist-fabricated 0.9 μm diameter circular
nanowells; (C) NHA fabricated with negative resist, coated with 30 nm of gold prior
to lift-off of nanopillars; The different colors of the individual patches indicate
distinct plasmon frequencies (D) Close-up of negative resist-fabricated 0.9 μm
diameter circular nanopillars; (E) NHA fabricated with negative resist, coated with
30 nm of gold following lift-off of nanopillars, revealing nanowells; (F) Close-up of
negative resist-fabricated 0.9 μm diameter circular nanowells.
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Nanostructures revealed shapes and sizes of desired dimensions. For example,
array number 10, enlarged in Fig. 3.3 (B) displays evenly shaped and sized nanowells, of
dimensions 0.9 μm. The precise control of shape and sizes, as well as their high
resolution indicate some of the benefits of electron beam lithography over nanosphere
lithography.
The variety of colours seen in in 3.3 C) under the same illumination conditions
are indicative of varying sizes and shapes of nanostructures and are known as plasmon
resonances.33 Nanostructures of different shapes, but of the same dimensions will reflect
and scatter light such that the waves of given frequencies will constructively interfere,
giving rise to colour.34, 35 This phenomenon is known as structural colour, and varies
from traditional colouring since the colour does not arise from the use of pigments. The
colours visualized are dependent on four main factors, namely the size, shape, dielectric
environment and illumination conditions.36 In other terms, changing the size and shape of
nanostructures changed the local refractive index, ultimately changing the colours
associated with the samples.
Initial characterization of metallic nanohole arrays by optical imaging was helpful
to ensure successful fabrication of desired nanostructures. However, scanning electron
microscopy was still required for full device examination. For example, during initial
fabrication steps involving nanopillars, nanostructures < 400 nm in size are difficult to
observe with a 100 × (N.A 0.9) objective. Additionally, different sized nanostructures
may require different area doses for optimal fabrication. Structures inscribed with a dose
greater than the optimal/nominal dose could display cracking, breaking, and may produce
structures larger than desired. In addition, deposition of metal on top of nanostructures
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could potentially lead to destruction of nanostructures due to the heaviness of metal
deposited, an observation best viewed under SEM conditions. Lastly, developing
nanostructures in solvent following lithography can cause removal of nanostructures if
the adhesion force between the nanostructure and substrate is weak. Removal of
nanostructures following developing in solvent would also be difficult to observe
optically for nanostructures tens of nanometers in size. SEM is therefore required to
assess these factors.

Figure 3.4 - SEM nanopillars and nanowells. (A) 200 nm circular nanopillars; (B)
900 nm circular nanopillars; (C) 900 nm square nanopillars; (D) 300 nm circular
nanowell; (E) 700 nm circular nanowells; (F) 600 nm square nanowells.
Figure 3.4 displays SEM images of nanopillars and resultant nanowells following
lift-off. A dose test was performed for all sizes and shapes of nanopillars to determine the
optimal electron beam energy density for each nanostructure. Optimal doses for circular
and square nanostructures are outlined in Table 2. Study of optimal doses for each
nanostructure was important to ensure for ideal resolution and correct sizing of structures.
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When a pattern becomes exposed at a lower dose than the optimal dose for best
resolution, this pattern is said to be underexposed. Underexposure may lead to a structure
width smaller than the desired structure width, and has also been found to increase the
probability of pattern irregularities.37 In contrast, exposing the nanostructure to a higher
dose, or overexposing (dosage is higher than the optimum dose) may lead to a widening
of the structure size. Tailoring the exposure dose for each nanostructure allowed for
fabrication of structures of desired width and shape.
Table 2 - Optimal electron beam dosage for fabrication of nanostructures of desired
sizes
Size (μm)

Dosage (μC/cm2)

0.1

100

0.2

110

0.3

105

0.4

110

0.5 – 1

90

Using the nanopillars shown in Figure 3.4 (A – C), nanoholes were produced in a
30 nm gold metal film. Following lift-off of nanopillars, SEM was used to validate
cleanliness of this the procedure. Important factors to assess were definition of edges of
nanostructures as well as residual resist remaining in nanowells. The lift-off procedure is
further illustrated in Figure 3.5, where (A) illustrates the intact nanopillar, (B) illustrates
lift-off with resist remaining in nanowells and (C) shows ideal structures with full
removal of resist.
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Figure 3.5 – Lift-off of nanopillars. (A) Intact nanopillar followed by (B) lift-off
revealing residual resist in nanowells, which is removed fully in (C), showing
exposed glass nanowells.
Any residual resist remaining in nanowells such as in Figure 3.5 B) could
interfere with materials sensed in welled areas during vibrational spectroscopic
acquisition. The protocol for removal of residual resist therefore incorporated nanostrip, a
formulation of sulfuric acid and hydrogen peroxide to remove this material without
damage to the gold metal film. Reactive plasma O2 treatment was additionally
incorporated to further remove/descum remaining resist in welled areas. This treatment
revealed clean lift-off of nanopillars and well-defined nanowells, indicating successful
fabrication of desired structures.

3.3.3

Plasmonic Properties of Metallic Nanohole Arrays
Further characterization of NHAs was allowed by absorption measurements.

Alterations in the physical parameters of the nanohole array such as hole size, periodicity,
thickness and type of metal shift resonances to different spectral locations.38
Characterization of absorption wavelengths was therefore important to determine optimal
wavelength(s) for SERS acquisition. Fig. 3.6 displays the absorption spectra of fabricated
nanohole arrays for square and circularly shaped nanoholes of 0.4, 0.6, 0.8 and 1 μm
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diameter. Spectra acquired for square wells indicate two resonances in the spectral ranges
between 620 - 630 cm-1 and 790 – 890 cm-1. Resonances associated with the circular
nanowells are seemingly less pronounced compared to the square nanowells. Two
resonances are depicted at 630 - 650 cm-1 and 820 - 850 cm-1 for circular nanowells.

Figure 3.6 – Absorption for horizontally polarized light through (A) square and (B)
circular nanowells of varying size.
To ensure the fabricated platforms were SERS active and to additionally
characterize the representative location of strongest SERS enhancement of the nanowells,
the surface of the NHA was functionalized for 24 hours in a 1 mM ethanolic solution of
4-mercaptophenyl boronic acid (4-MPBA). 4-MPBA is a well characterized Raman
reporter known to form a self-assembled monolayer with gold, through a strong sulfurmetal bond. It additionally has applications in biosensing.39, 40 Fig. 3.6 displays Raman
maps for a 0.9 μm circle and 0.9 μm square integrated over the 1074 cm-1 peak
correlating to the B-OH stretch41 (integration range 1055 – 1100 cm-1). Maps indicate the

50

strongest enhancement lies in the central cavities of the nanoholes, a promising finding
for sensing nanoscale materials in these confined regions.
Representative SERS spectra of 4-MPBA maps are displayed in Fig. 3.7 (C, F).
SERS-active areas show a strong 4-MPBA signal in central regions of the nanohole array,
as depicted by spots 1 and 3, whereas areas with a lower SERS enhancement (spots 2 and
4) show a negligible 4-MPBA signal. Optimal areas of sensing biological materials such
as EVs would therefore lie in the central cavities of the NHAs.

Figure 3.7 - Mapping of 4-MPBA on a nanohole array surface with f. (A) SEM
image of 0.9 μm diameter circular nanohole; (B) SERS map of corresponding
nanohole; (C) SERS spectra of pixels indicated in (B); (D) SEM image of 0.9 μm
diameter square nanohole; (E) SERS map of corresponding nanohole; (F) SERS
spectra of pixels 3 and 4 selected in (E).
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As displayed in Figure 3.7, the SERS enhancement is localized within the central
cavity of the circular or square nanowells. Due to the beam diameter and step size, we
observe an overall enhancement over the entire surface of the nanohole cavities, whereas
no distinguishable SERS response is observed on the nanofilm area (areas 2 and 4). Due
to the spot-size of the objective (~ 1 micron), we are not able to achieve sufficient spatial
resolution to map the edges of structures with higher resolution. Since no signal is
observed from the bare gold substrate, the SERS-active regions are located at the outer
edges of the nanostructures.

3.3.4

Trapping Capabilities of Nanohole Arrays
Trapping of nanomaterials (polystyrene spheres) within nanowells was

characterized with non-plasmonic nanohole arrays fabricated with a positive resist. To
trap polystyrene spheres in nanohole arrays, either 1.0 μm fluorescent polystyrene
spheres or 0.2 μm non-fluorescent polystyrene spheres were drop casted onto circular and
square nanoholes and allowed to settle for 30 minutes. The non-trapped polystyrene
spheres were removed by application of an absorbent wipe in the corner of the droplet
containing the polystyrene solution. This allowed for semi-controlled positioning of
polystyrene, as cohesive forces resulted in confinement of PS spheres to the edges of the
nanowells, as seen in Fig. 3.8.
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Figure 3.8 - Polystyrene spheres trapped within PMMA nanohole arrays. (A)
Nanohole array of 0.3 μm circles with 0.2 μm polystyrene beads (B) nanohole array
of 0.4 μm squares with 0.2 μm polystyrene beads (C) 1.0 μm fluorescent polystyrene
beads trapped in 1 μm circular wells. (D) 1.0 μm fluorescent polystyrene beads
trapped in 0.9 μm square wells.
In cases where nanowells were larger than the diameter of polystyrene spheres,
more than one sphere could become trapped within an individual well, as seen in Fig. 3.8
B). This is an undesirable finding for vibrational spectral acquisition due to the inability
to isolate overlapping spectral peaks. However, when the size of the well has similar
dimension than of the sphere, trapping was noted as more precise (Figure 3.8 A).
Therefore, when possible, characterization of the size range of the trapped materials is
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helpful. In the case of polystyrene, the aspect ratio and exact dimensions of the beads are
known allowing for semi-precise control over the dimensions of wells to best allow for
successful, non-aggregated trapping.
The location of trapping of polystyrene spheres is a point of great interest. The
direction of placement of the absorbent paper in the final step of the trapping protocol
indicates the direction of trapping of polystyrene spheres, as the spheres are pulled in the
direction of the capillary force. Spatial control when trapping materials smaller than the
size of the wells is highly desired for spectroscopic analyses, as control over the location
of materials may allow for automation of optical measurements since each nanomaterial
may be referenced by a set of spatial (x,y) coordinates.
The ability to steer trapped objects to a desired location within nanowells also
highlights another important benefit of using electron beam lithography to fabricate
plasmonic materials versus nanosphere lithography. The use of a resist, matched with
control over the acceleration energy of electrons used to fabricate EBL patterns allows
for control of depth of wells for trapping. In contrast, nanosphere lithography does not
allow for controlled spatial positioning in the same manner as EBL, as the large quantity
of defects and inability to fabricate deeper wells via a resist makes it difficult to trap
objects reproducibly in controlled locations.
To further analyze the trapping abilities of nanohole arrays, the same
methodology as described for trapping of PS microspheres within the non-plasmonic
NHAs was used with a plasmonic nanohole array fabricated with a negative resist. Once
polystyrene spheres settled into nanowell cavities, it was possible to probe the SERS
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spectra from each individual PS sphere from both above and below/through the nanohole
array. Probing of SERS spectra above the nanohole array was successful, however
sensing of PS spheres from below the NHA was of specific interest to confirm that PS
microspheres were in-fact sitting within individual nanowell cavities. This experiment is
shown in Figure 3.9.

Figure 3.9 - Sensing of polystyrene spheres through a nanohole array. The sample
was mounted face-up, facing away from the laser beam source. (A) Areas of interest
for SERS spectral acquisition. Area 1 highlights a trapped polystyrene sphere 1 μm
in diameter trapped within a nanowell, whereas area 2 corresponds to a background
area with no trapped material. Corresponding spectra to (A) are displayed in (B),
where area 1 displays a peak characteristic of polystyrene and area 2 lacks this
spectral peak.
Figure 3.9 B) displays a SERS spectrum obtained from a nanohole array with PS
trapped in nanowells, facing away from the excitation laser. The peak located at 1000
cm-1 corresponds to the aromatic breathing mode of the benzene ring and was chosen as a
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reference peak due to its strong intensity.42 Sensing of materials through the nanohole
array in confined nanowells was indicative of successful capturing of materials within
desired areas. This finding is also promising for extending use of this nanodevice to a
broader set of applications such as trapping of extracellular vesicles, proteins, nucleic
acids, or growth factors. Incorporation of this nanodevice into point-of-care technologies
is also promising based on these findings.

3.4

Conclusions
In this chapter, two methods are introduced to fabricate plasmonic nanostructured

substrates for surface-enhanced Raman spectroscopy. Nanosphere lithography was
successfully performed and characterized with absorption measurements, revealing
structures with well-defined LSPR positions. Electron beam lithography was also
completed to allow for better control with positioning of nanostructures. Two separate
protocols of EBL were successfully demonstrated, one on a positive resist for trapping of
nanoscale materials, and one on a negative resist for acquisition of SERS spectra. The hot
spots of nanohole arrays were mapped with a well-known Raman reporter (4-MPBA),
which successfully demonstrated that hotspots lie within central cavities of wells,
highlighting ideal sensing areas for materials. Sensing was further tested with
polystyrene spheres. Trapping of nanoscale polystyrene spheres displayed controlled
positioning of materials within desired welled areas, which may allow for future
automation of spectral acquisitions to well-defined sets of spatial coordinates. The SERS
spectrum of a trapped polystyrene sphere was also successfully acquired from below a
nanowell and referenced to the background, indicating successful localization of material
within confined areas.
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Chapter 4
Surface-Enhanced Raman Spectroscopy of
Extracellular Vesicles

4

4.1 Introduction
As cells grow and divide, extracellular vesicles are actively released. The
umbrella term extracellular vesicle (EV) encompasses three main subgroups of vesicles
that are classified by their size: (i) exosomes, (ii) microvesicles, and (iii) apoptotic
bodies.1 The different classifications of vesicles originate from distinct regions of cells
and through different cellular processes. Depending on the origin of the EV, the
biochemical composition of the membrane and internal cargoes may vary. As EVs are
formed, biomolecules including DNA, mRNA, lipids, and proteins from the parent cell
are introduced into the cytosolic core.2 Examining both the external and internal
components of the extracellular vesicle may be used as a means of determining the source
and modes of action of specific EVs within the body.
The study of EVs has intensified in recent years due to their potential diagnostic
and prognostic applications. EVs have been found to play important roles in disease
progression and have been related to neurodegenerative diseases such Alzheimer’s3, 4 and
Parkinson’s diseases5, 6, as well as prostate1, 7-9, lung10 and breast cancers11, 12. One
diagnostic approach to examine biomarkers incorporated in EVs is by western blotting13,
14

. This approach is particularly useful for comparing EVs originating from healthy and

diseased cells, as different biomarkers may become overexpressed or expressed to a
greater degree in diseased states. For example, the expressions of exosome biomarkers
present in breast cancer patients are significantly higher when compared to healthy
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controls or benign breast tumor patients. There is potential to use these biomarkers for
detection and diagnosis of breast cancer.13
Isolation of EVs from human biofluids, such as tears,15 urine,16 blood,7, 11, 16 and
cerebrospinal fluid3 present many challenges for researchers. Their isolation from other
biological components such as free-floating proteins and cell debris highlights the
fundamental importance of being able to capture and probe the EVs at low quantities. It is
necessary to note that although there is a correlation amongst a parent cell and the EVs it
releases, the presence and distribution of biomarkers may vary depending on the type,
mode, and location of the vesicle released. Therefore, a given parent cell releases EVs
with varying biomarker expressions.17 As such, techniques capable of identifying the
variability and presence of biomarkers at the single EV level in short periods of time are
of great interest.
Recently, several novel methods have been reported indicating noteworthy
progress towards detection and characterization of individual EVs. For example, Hu et al.
incorporated surface plasmon resonance (SPR) sensing into antibody-specific
microarrays to detect and sense individual exosomes.18 Microarrays were functionalized
with antibodies complementary to membrane surface proteins of exosomes, allowing for
immobilization of individual of exosomes upon interaction. Changes in the local
refractive index at the surface of the nanodevice signaled successful binding events for
enumeration. This method was successful at counting individual exosomes, however it
required labelling with antibodies. As a result, any exosomes lacking the antigen on their
membrane surface, or expressing a low quantity of antigens on their surface may not been
eliminated from final counts. Alternatively, nanoparticle tracking analysis (NTA) has
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been presented in recent years as a technique to quantify individual exosomes in realtime. Song et al. utilized NTA to quantify exosomes collected from human sweat
samples.19 NTA employs a laser beam to measure and single particle size and
concentration of particles in solution. This technique was successful at quantifying
exosome counts, however was not capable of providing molecular or proteomic
information without incorporation of additional techniques such as western blotting. In
addition to SPR sensing and NTA, Raman spectroscopy and surface-enhanced Raman
spectroscopy (SERS) have emerged as promising techniques for quantification of
individual EVs.
Raman spectroscopy is a well-established technique for characterizing biological
materials. It provides molecular information in a non-destructive and label-free manner,
making it a highly useful technique for studying biological materials in their natural
environments. It has been applied to a variety of biological studies including cancer
studies,20,21 neurodegenerative diseases,22,23 immunology24,25 and microbiology26,27. It has
previously been utilized as a tool to study extracellular vesicles by laser tweezers Raman
spectroscopy (LTRS), which utilizes a tightly focused laser beam to trap particles at the
lasers focal point. Smith et al. used LTRS to trap and discern the similarities and
differences amongst individual exosomes isolated from eight different cell lines.28 Since
LTRS is a label-free technique, no prior knowledge of surface proteins was required.
They reported spectral variability in the relative expressions of phospholipids to
cholesterol amongst exosomes released when comparing cancerous to non-cancerous cell
lines. They were also successful in trapping and probing molecular information from
individual exosome. Braeckmans et al. attempted to characterize the diversity of
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individual exosomes isolated from different cell lines based on a nanoparticle approach.29
Deposition of a gold nanoparticle shell allowed for SERS sensing of exosomes. The study
was successful at identifying and characterizing individual exosomes, however their
isolation protocol introduced intense SERS peaks from background reagents, which
limited the information gained by the study.
Detection of individual extracellular vesicles from human biofluids or cell culture
supernatant is often a challenge due to lack in characterization methodology and lack of
standardization in isolation protocol. Of the many methods proposed for isolation, some
of the most common methods are differential/gradient ultracentrifugation and low-speed
centrifugation by commercial isolation reagent kits.30 Ultracentrifugation techniques are
known to be time-consuming and tedious, but have yielded good purification results.
Commercial isolation reagent kits lack specificity in isolation. These kits act by
precipitating vesicles with polyethylene glycol or similar polymers, which ultimately
results in contamination of isolates with the polymeric agents.17, 29 This largely limits
vibrational spectroscopy results, as peaks from isolation reagent kits may predominate
over the natural/intrinsic spectral response of the biological materials.
In this chapter, a new approach to detect the chemical content and presence of
bulk EV samples with surface-enhanced Raman spectroscopy (SERS) is presented. We
additionally extend this work to detection and trapping of individual EVs using nanohole
arrays (NHAs). EVs from a pancreatic mesenchymal stromal cell line were isolated to
analyze the similarities and differences amongst EVs. Protocols used for EV isolation
aimed to minimize spectral contamination from backgrounds to ultimately extract
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molecular information directly from EVs by use of centrifugation and filtration
methodologies.

4.2 Experimental
4.2.1 Cell Culturing of Pancreatic Mesenchymal Stem Cell Line
Ricordi-chamber isolated human islets were obtained through the Integrated Islet
Distribution Program (IIDP) funded by the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK). 200 islet equivalents were cultured in RPMI 1640 + 10%
FBS (Thermo Fisher) for up to 7 days. Between days 5-7, cells with a mesenchymal stem
cell (MSC) phenotype1 were trypsinized and segregated from adherent islet preps using a
40𝜇m cell strainer (Corning). Single cell suspensions were subsequently seeded on tissue
culture plastic at 4,000 cells/cm2 in Amniomax-C100TM (Gibco Life Technologies)
supplemented with AmniomaxTM E100 Supplement (Gibco Life Technologies) to
support MSC colony formation. Primary human pancreatic cells were deemed to be
tissue-specific MSC (Panc-MSC), according guidelines established by the International
Society of Cellular Therapies. Panc-MSC were passaged when flasks reached 80-90%
confluency and utilized for experimentation at passage 4. Cells were enumerated using
Countess II FL (Life Technologies) prior to subsequent experimentation.

4.2.2 Isolation of EVs from Mesenchymal Cell Line
Conditioned media (CM) was generated by culturing Panc-MSC to ~80%
confluency, rinsed twice with pre-warmed PBS, and cultured for 24 hours in serum-free
Aminomax C100. To remove contaminating dead cells or debris, MSC-CM was
centrifuged at 600g for 7 minutes. Cell-free MSC-CM was centrifuged in Amicon Ultra15 100kDa centrifuge filter units (Millipore) for 20 minutes at 2800g. This concentrated
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fraction is enriched with extracellular vesicles (EV+ MSC-CM) and depleted proteins
<100kDa. EV+ MSC-CM was rinsed twice with deionized water to remove any residual
phenol red from prepared samples.

4.2.3 Cell Culturing of Human Prostate Cancer Cell Line (PC3)
Human prostate cancer cell line, PC3 cells were obtained from ATCC (CRL
1435TM, Manassas, VA, USA) and maintained in Roswell Park Memorial Institute
(RPMI)-1640 medium (Wisent, Saint-Jean-Baptiste, QC) and supplemented with 10%
fetal bovine serum (FBS, Wisent, Saint-Jean-Baptiste, QC). The cultures were maintained
and grown to a confluency of ~80% in an incubator at 37 °C, 5% CO2, 100% humidity for
three to four days. For fluorescent studies, human PC3 cells were labelled with zeta-green
through a lentiviral transduction according to a protocol similar to Swaison et al.31
To grow additional cells, cells were split by rinsing with phosphate-buffered
saline (PBS) (Wisent, Saint-Jean-Baptiste, QC) followed by treatment with trypsinEDTA (Wisent, Saint-Jean-Baptiste, QC) and incubation for 2-5 minutes in 37°C, 5%
CO2, 100% humidity for detachment. Twice the quantity of RPMI, supplemented with
10% FBS was added to the trypsinized cells for neutralization, after which cells
suspended in trypsin and culture media were centrifuged at 250 g for two minutes to
pellet cells. Supernatant was collected for exosome extraction, and the cellular pellet was
re-suspended in cell culture media in new flasks with RPMI for further cell growth and
EV isolation. Flasks were incubated under the same conditions as mentioned above until
cells reached a confluency of ~ 80%.
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4.2.4 Isolation of EVs from Human Prostate Cancer Cell Line (PC3)
Following cell culturing and media isolation as described in section 2.1, collected
media containing released EVs was centrifuged at 250 g for 5 minutes. Pellets of
remaining cells were discarded and supernatant was poured into an Amicon EMD 100
kDa Millipore filter (Millipore Sigma), centrifuged at 3200 g for 20 - 30 minutes, while
shaking every five minutes to reduce the concentration gradient between the filter and
filtrate. Timing of centrifugation varied between 20 – 30 minutes depending on the
volume and concentration of EVs being sorted through the Millipore filter. EVs were
collected and placed into Eppendorf tubes, and stored at – 20 °C for up to 1 month, or at
– 80 °C for long-term storage.

4.2.5 EV Preservation for SEM Imaging
For scanning electron micrograph (SEM) purposes, preservation of EVs to retain
their natural spherical shape without bursting upon drying was carried out according to
protocol by Wu et al.32 EVs isolated from media were fixed in 4 % paraformaldehyde
(PFA) (v/v) for 10 minutes. After which, the process of preservation was completed by
adding 20% dimethyl siloxane (DMSO) (v/v) to the sample. The sample was aliquoted
into vials and stored at – 20 0C for up to one month prior to use.

4.2.6 Substrate Fabrication and Trapping of EVs within Nanohole
Arrays
Fabrication of NSL substrates and metallic nanohole arrays followed the protocols
outlined in 3.2.1 and 3.2.2.2. To prepare nano-array samples, concentrated EV samples
were diluted with milli-Q water. The dilution factor varied based on the concentration of
EVs in the sample, and dilutions were either 1:2, 1:3, 1:4, 1:5 or 1:10 depending on the
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sample. 20 μL of EV-water solution was drop-casted onto the nano-arrays fabricated by
EBL (see section 2.2) and allowed to dry for 20 – 30 minutes to trap EV within nanowells. Removal of EV-water solution from the array was performed using the cohesive
properties allowed by an absorbent paper (Kimberly-Clark Inc.). The edge of the
absorbent paper was placed onto the corner of the solution droplet, allowing for removal
of solution via capillary action.

4.2.7 Spectroscopic Characterization
Raman spectra were obtained with a Horiba Jobin-Yvon Raman spectrometer
equipped with a 600 grooves/mm grating and a 623.8 nm excitation source. An optical
objective of 100 × (N.A 0.9) was used to collect backscattered light. The pinhole of the
spectrometer was opened to 200 μm. Acquisition time was 20 seconds per spectra, and
power at the sample was 0.5 mW. For SERS mapping experiments of 4-MPBA, an
acquisition time of 5 seconds was used. For SERS measurements with extracellular
vesicles, laser power was 0.5 mW at the sample and exposure time varied between 20 –
100 s.

4.3 Results and Discussion
4.3.1 Characteristics of EVs
The human prostate cancer cell line, PC3 was used for characterization of EVs.
This cell line was chosen due to its ability to grow, proliferate and produce EVs rapidly.
In addition, this cell line is straight-forward to work with, requiring standard cellhandling protocols and is a cell line of interest for this research project due to its
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cancerous nature. Optical, fluorescence and scanning electron micrograph (SEM) images
were obtained of growing cell cultures, as indicated in Figure 4.1.

Figure 4.1 – Images of a healthy PC3 cell line used for EV isolation and
characterization (A) Optical image of a growing cell culture, with its corresponding
fluorescence image (B); (C) SEM of a healthy PC3 cell, displaying sharp edges and
protrusions.
Optical and fluorescence images were obtained to determine confluency and health of
growing cell cultures. Live-cell images were obtained with an EVOS FLoid Cell Imaging
Station (Thermo Fisher Scientific). For concentrated extraction of EVs in cell culture
media, the confluency of cells was measured to be > 80%. Therefore, images 4.1 (A) and
(B) display confluencies too low for EV isolation but show healthy cell cultures for
eventual EV isolation. Cells depicted in these images would require a few additional days
for growth before EVs extraction takes place. A SEM image is included in Fig. 4.1 (C) to
highlight the characteristic morphology of healthy PC3 cells. Healthy PC3 cells are
polygonal in shape, have sharp boundaries between adjacent cells and have
characteristically long ‘arm-like’ projections radiating from their sides.33

68

Figure 4.2 – Images of isolated EVs. (A) Fluorescent image of isolated EVs (B)
preserved EVs on a silicon wafer.
Isolation of EVs was validated by fluorescence microscopy and SEM. The
fluorescence image in Figure 4.2 A) displays a large quantity of isolated vesicles varying
in size. There also exists a variability in fluorescence, highlighting a fundamentally
important aspect of cellular release of EVs. When parent cells are stained with
fluorescent dye, the dye becomes integrated into different areas of the cell in variable
amounts. Depending on the location and method of release of each EV, it is expected that
EVs may display differences in their fluorescence intensities based on their mode and
location of release.34
To visualize the spherical nature of EVs, protocol by Wu et al.32 was followed to
preserve EVs, which involved immersing the EV solution in 4% PFA (v/v) followed by
treatment with 20% DMSO (v/v). Preserved EVs show their expected, characteristic
spherical shape (Figure 4.2 B). EVs outlined in this image display a dramatic size
difference and are therefore thought to be a larger EV (apoptotic body) attached to a
smaller EV (microvesicle). Both vesicles would be released through different cellular
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mechanisms, and likely adhered to one another during fixation. It is important to note
that although preservation of EVs maintains structural integrity, the PFA and DMSO
used for preservation may lead to spectral changes to the natural spectroscopy of EVs,
making this method ideal for imaging and trapping of EVs, but non-ideal for spectral
acquisition.

4.3.2 SERS of EVs (PC3)
Following successful isolation of EVs, it was desirable to probe their spectral
characteristics by SERS. Nanosphere lithography substrates were fabricated to obtain
preliminary SERS spectra to determine the biochemical makeup of bulk sets of EVs.
Vesicles were drop casted onto NSL substrates and allowed to dry overnight. The sample
was then mounted in an inverted configuration, facing the 633 nm He-Ne laser.

Figure 4.3 (a) NSL substrate containing dried EVs, of which a (b) SERS spectra was
obtained of an EV (red) and of the background (blue).
Figure 4.3 outlines setup of the spectroscopic experiments. First, the laser was
focused on the EV (highlighted in red). Following acquisition of this spectra over a 20second period, the laser was moved to the background area beside the dried EV for

70

comparison (highlighted in blue). Representative spectra are shown in Figure 4.3 (B).
The sharp, well defined peaks obtained from the EV were compared to those presented in
the literature and displayed many commonalities with EVs previously probed with
Raman and SERS (Table 3). Commonalities with previous spectroscopic experiments on
EVs included peaks correlating to lipids, nucleic acids and proteins such as the ν(C-C)
peak at 1139 cm-1, the C–O ribose nucleic acid stretch at 1109 cm-1 and the δ(CH2/CH3)
protein or lipid stretch located at 1444 cm-1. Differences also existed when compared to
the literature. These variations are expected to exist not only amongst EVs released from
different cell lines, but also within a given cohort of EVs released from the same cell
line.35, 41, 42
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Table 3 - SERS peak assignment for PC3 EV
Raman Shift
(cm-1)

Presumed Origin/Assignment of Peak

Reference

1039

ν(C-C) (lipid)

22, 44

1110

ν(C-O) (nucleic acid)

22, 44

1142

ν(C-C) (lipid)

43

1330

ω(CH3CH2) (nucleic acid)

22, 44

1412

δ(CH2) (lipid)

22, 43

1444

δ(CH2/CH3) (protein, lipid)

22, 35, 44

1569

ω(CH2/ CH3) tryptophan (nucleic acid)

22, 44

1667

v(C=O) Amide I (protein, cholesteryl ester)

35, 43, 45

2976

v(CH3) (lipid, fatty acid, cholesterol ester)

43

To confirm consistency in peaks acquired from EVs of the PC3 cell line,
additional SERS spectra were acquired on NSL substrates. A high degree of similarity
was noted, as seen in Figure 4.4. Note that the green trace corresponds to the spectra
previously displayed in Figure 4.3 (B). Peaks outlined in Figure 4.4 showed a high degree
of similarity to those previously outlined in Table 3. Additional peaks arose for lipids and
carbohydrates between 2900 – 3400 cm-1, noting C-H and unsaturated =CH stretches.43
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Figure 4.4 – SERS spectra obtained from PC3 derived EVs on a NSL substrate
prepared by the O-ring method.
To confirm that vibrational peaks arose from EVs rather than background
contamination from cell culture reagents, background spectra were acquired for all agents
used during cell culture and EV isolation. These background spectra include (1) RPMI
media; (2) RMPI media supplemented with 10% fetal bovine serum; (3) fetal bovine
serum; (4) PBS buffer and (5) Trypsin-EDTA. Concentrated solutions of each
background solution were drop-casted onto individual glass cover slips and probed by
Raman spectroscopy. Representative spectra for these backgrounds, acquired over 10
second acquisition times are displayed in Figure 4.5.
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Figure 4.5 – Representative background spectra from PC3 cell line.
Background spectra did not display any sharp spectroscopic peaks and therefore
do not compare to those previously acquired for EVs. SERS peaks obtained from EVs on
NSL substrates may be assigned directly to the EVs, rather than from spectral
contamination by background agents.
To gain a better understanding of the variability that exists amongst vesicles released
from different cell lines, a mesenchymal stem cell line was cultured for EV isolation.
Study of EVs released from mesenchymal stem cells have applications in regenerative
medicine,40 and in studies for organ injury repair.41 A NSL-based experiment was
prepared in the same manner as previously outlined PC3 isolated EVs. Spectra were
acquired for 100 s, and three representative spectra are shown in Figure 4.6.
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Figure 4.6 – SERS of EVs from a mesenchymal stem cell line on a NSL platform.
These spectra display similarities and differences when compared to one another.
These similarities and differences are further discussed in 4.3.3.

4.3.3 Trapping and Spectral Probing of EVs in NHAs
To visualize trapping of EVs within nanowells, a diluted solution was prepared by
mixing EVs with milli-Q water in a 1:3 v/v ratio. The solution was drop-casted onto the
nanohole array substrate, and an absorbent wipe was placed on the nanohole array to
remove excess and non-trapped EVs. Trapping of EVs displayed similar trapping patterns
compared polystyrene particles, previously characterized in 3.3.4.
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Figure 4.7 – SEM images of EVs trapped within (A) a square nanowell of 0.8 μm
diameter; (B) a 1 μm diameter circular nanowell (C) a 0.5 μm square nanowell; (D)
optical image of a 1 μm diameter square nanowells.
Figure 4.7 displays SEM and optical images obtained for trapping of EVs within
nanowells. Within the 0.8 μm diameter square nanowell, two EVs visibly became trapped
in opposite corners. The spectral readout of this nanowell would therefore likely
correspond to both EVs, therefore delineation of peaks arising from one EV would not be
possible. To this point, if a 100 × objective with a N.A of 0.9 was utilized for
spectroscopic measurements, the laser focal diameter would measure roughly 1 μm in
diameter, probing information from the entire nanowell. However, in cases where one EV
becomes trapped within a given well, the spectral information of one EV would be
probed. Trapping of one EV per nanowell is the desired result of this experiment,
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however it is important to recognize that probed spectra may be resultant from the
spectral overlap of more than EV due to the beam diameter. To allow for more precise
trapping of only one EV per well, possible experimentation could be to functionalize
nanowells with antibodies for capture based on membrane antigens/proteins.42 Dilution of
antibodies and functionalization could allow for more precise control over capture. Since
this work seeks to minimize spectral contamination from background reagents, capture by
antibodies was not explored.
In Figure 4.7 C), an EV larger than the diameter of the nanowell became trapped,
and eventually ruptured. This trend is promising for capture and probing of larger sized
EVs. An optical image is also provided in Figure 4.7 D) to highlight the trapping
efficiency of EVs within a given array of wells. The bright yellow colours correspond to
dried cell culture media or background agents used for isolation of EVs, whereas the
darker regions within welled areas are thought to correspond to trapped vesicles.
Trapping efficiency in this case is quite high for the 1 μm diameter square nanowells,
although variability has been noted to exist when comparing samples.
Following trapping and sorting of EVs within metallic nanohole arrays, SERS
spectra were acquired. SERS spectra of the mesenchymal cell line obtained within the
NHA correlated strongly to those previously obtained on the NSL substrate. Background
spectra of cell culture media is shown in Figure 4.8, and three representative spectra are
shown in Figure 4.9.
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Figure 4.8 - Background Raman spectra of cell culture media for mesenchymal stem
cell line.
Background spectra display no defined Raman peaks that would interfere with the
intrinsic SERS response of EVs. Acquisition times ranged between 10 – 100 s for the
spectra displayed.
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Figure 4.9 - SERS of EVs trapped in a nanohole array within (1) 0.7 μm diameter
circular well; (2) 0.9 μm diameter square well; (3) 0.8 μm diameter square. Spectra
are shifted for clarity.
The Raman spectra selected are representative of the data set acquired, and were
selected due to their similar intensities, thereby eliminating any need for data processing
software for enhancement signal to noise ratios. The spectra displayed common
vibrational peaks. The intensities of predominant peaks varied, which we hypothesize is
due to the intrinsic differences amongst the EV population, even when released from the
same cell line. The peaks arising at 669, 1320 and 1602 cm-1 come from nucleic acids and
amino acids.29, 37, 43 The peak located at 1386 cm-1 present in spectra 1 and 2 corresponds
to a δCH3 vibration, most likely associated with the membrane of the vesicles. Depending
on location of entrapment within the nanowell, it is possible that this membrane vibration
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was not detectable for the vesicle probed in spectra 3. The strong peaks between 1490
and 1497 cm-1, present in all three spectra correlate to δ C-N/ ν (N-H), likely from an
amide II stretch in proteins.37 The peaks present between 1566 and 1576 cm-1 correlate to
the nucleic acids or proteins such as tryptophan, guanine and phenylalanine,
respectively.29, 37 These results provide information regarding variability at the single
vesicle level, information that may be used to further clarify the roles of EV subtypes in
reference to their chemical makeup and ultimate biological function(s).
Table 4 - SERS peak assignment for mesenchymal EVs
Raman Shift
(cm-1)

Presumed Origin/Assignment of Peak

Reference

669

ν(C-S) cytosine (nucleic acid)

37

700

ν(C-S) methionine (protein)/ ν(C-C) cholesterol
ester (lipid)

38, 37

1320

ω(CH3CH2) (nucleic acid)

29, 37

1344

δ(CH) deformations (lipid or nucleic acid)

44

1379

δCH3 (lipid)

29

1386

δCH3 (lipid)

29, 37

1494

δC-N/ ν(N-H) (protein)

37

1566

ν(C-C) tryptophan (nucleic acid)

29, 44

1576

δ(C=C) phenylalanine (protein)/ guanine (nucleic
acid)

44, 29

1602

ν(C=C) phenylalanine (protein)

43
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The intensity differences amongst spectra in Fig. 4.9 are believed to be resultant
from a variety of factors. These factors include the presence and non-presence of
biomolecules such as proteins and nucleic acids as well as the distribution of these
biomolecules. Additionally, upon entrapment and bursting of extracellular vesicles in air
conditions, some contents may burst on the edges or sides of the nanowells.38 Bursting of
the EVs on the edges of plasmonic nanowells is expected to yield a greater enhancement
compared to the glass area in the center of the wells. We would therefore expect to see a
variation in response due to these factors.
The height differences between peaks shared amongst the spectra are
hypothesized to be indicative of the varying cargoes present on the surface and within the
EVs. For example, the peak present in spectra 1 and 2 at 669 cm-1 is indicative of a
different quantity of nucleic acids present in each vesicle. Previous literature has reported
that nucleic acids may be present on the external surface or within the central cavities of
EVs.45 The increased strength of this peak in spectra 2 compared to spectra 3 may be
indicative of the presence of DNA/RNA on the surface of the EV in spectra 2. This likely
would yield a more intense signal, as the DNA would be located closer to the metallic
nanohole array generating the greatest electromagnetic enhancement by SERS. However,
it is also possible that these nucleic acids may have been released upon drying and
bursting of the EVs within the nanowells.38 These findings suggest that for one given
class of EV, there exists a diversity in the biochemical composition and distribution of
biological cargoes.
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4.3.4 Extracellular Vesicle Differentiation and Similarity
When the spectral characteristics of the PC3-derived EVs are compared to the
mesenchymal stem cell produced EVs, similarities are noted for nucleic acid, protein and
lipid stretches. Figure 4.9 highlights commonalities and differences amongst these
vesicles.

Figure 4.10 - Comparison of SERS spectra of EVs probed by NSL from
mesenchymal and prostate (PC3) cell lines.
A high degree of similarity is noted when comparing SERS spectra from EVs of
varying origin. Analysis of common peaks arising from individual EVs derived from
different cell lines suggests conserved biological functions. Since membrane components
are composed of lipids a high degree of overlap for peaks arising from membranous
lipids is expected. In addition, since EVs are released through the cytosolic center of
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cells, proteins and nucleic acids packaged into their core are expected to be universally
present. Peaks common amongst both EV lines are assigned in Table 5.
Smith et al. noted similar findings, suggesting conserved biological function
amongst EVs released from seven different cell lines.28 Using statistical analysis
(principle component analysis), cholesterol content, surface protein expression and the
relative expression of phospholipids to cholesterol were highly conserved. Statistical
analysis by principle component analysis would be of great interest for discerning the
most common peaks shared amongst the two EV lines studied in this work. PCA could
also be used to generate a library or barcoding system to definitively differentiate and
compare EVs, which has previously been suggested in the literature.46, 47 Barcoding of
EVs by SERS could provide potential benefits in disease diagnosis, as understanding the
variability shared amongst one EV line and between different EV lines may potentially
allow for definitive detection of biomarkers present in diseases and cancers. To perform
statistical analysis, large sets of data would be required. Multiplexing by on-chip sensing
would assist greatly in acquisition of large data sets. Automation of spectroscopic
measurements of fabricated NHAs by defining each nanowell to a set of spatial
coordinates may potentially allow for this type of analysis in future work.
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Table 5 - Peak assignment for peaks shared amongst PC3 and mesenchymal EVs
Raman Shift
(cm-1)

Presumed Origin/Assignment of Peak

Reference

695 - 705

ν(C-S) (methionine, protein) / ν(C-C) Cholesterol
ester (lipid)

38, 37

895 – 900

ρ(CH2) (protein)

29

1110 - 1115

ν(C - O) (ribose, nucleic acid)

29

1310 – 1330

ν(C- N) (protein)/ τ(CH3CH2) (lipid)

29

1570 - 1575

ν(C-C) Tryptophan (nucleic acid)

29, 44

4.4 Conclusion
Throughout this chapter, isolation of EVs was successfully verified by
fluorescence and scanning electron microscopy. Fixation of the membranes of EVs
revealed intact, spherical membranes and displayed a variation in size verifying
successful isolation of exosomes, microvesicles and apoptotic bodies. Trapping of EVs
was subsequently characterized by fabrication of nanohole arrays, which revealed capture
of EVs in corner regions of square and circular nanowells. Nanohole arrays with
plasmonic capabilities were also fabricated for compatibility with surface-enhanced
Raman spectroscopy.
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Sorting and probing by SERS of individual extracellular vesicles was allowed by
fabrication of metallic nanohole arrays. SERS results presented good agreement to those
presented in the literature, showing presence of expected lipid, protein and nucleic acid
peaks. Raman spectra of background reagents further concluded that peaks were from
intrinsic EV signatures. This approach therefore eliminates the need for background
subtraction from isolation reagent kits, as direct isolation of EVs occurred by
combination of filtration and centrifugation.
Amongst EVs isolated from the same cell line, similarities and differences were
noted, suggesting some EVs contain higher quantities of biomolecules compared to
others. Comparison of EVs isolated from two different cell cultures also showed
similarities and differences. Similarities included nucleic acid content as well as lipid and
protein content, suggesting conserved biological functions. We therefore demonstrated
that nanowell-based SERS substrates may be used to capture and probe nanomaterials for
molecular-level characterization. This nanodevice holds high potential in point-of-care
diagnostics for cancer or disease detection.
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Chapter 5

5

Conclusions and Outlook

5.1 Conclusions
Nanofabrication techniques such as nanosphere lithography and electron beam
lithography are promising methods of fabricating metallic nanostructures in a
reproducible manner. Although the applications of metallic nanostructures vary widely
across scientific subdisciplines, they have been used extensively for spectroscopic
analyses due to their plasmonic capabilities.1-5 Incorporation of nanostructures into chipbased sensors holds extreme potential in development of point-of-care technologies for
disease detection and diagnosis. Recently, chip-based sensors involving nanofabrication
techniques have developed devices with extreme sensitivities to study a variety of
biological, physical and chemical phenomena.6-8
Throughout this thesis, nanosphere lithography and electron beam lithography
were presented as lithographic techniques to probe molecular information from biological
vesicles. Chapter 1 highlighted current work within the fields of nanofabrication,
extracellular vesicles and point-of-care sensor development. Chapter 2 presented the
main biological, chemical and physical information underlying extracellular vesicles and
nanofabrication. Specific interest was also placed on direct and indirect sensing of
biomaterials for disease diagnosis and detection.
Fabrication and characterization of nanostructures and substrates were
characterized throughout Chapter 3, wherein the LSPR positions of NSL and EBL
structures were obtained by absorption measurements to allow for matching of LSPR
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positions with the incident light source. The O-ring method of NSL was offered as a
means of fabricating reproducible and semi-controlled regions of nanoprisms.9 EBL was
further performed on a positive-tone resist to assess the trapping capabilities of nanowell
cavities with polystyrene spheres of a known aspect ratio. These samples were
characterized by SEM, fluorescence and optical imaging. Results indicated successful
fabrication of nanostructures by NSL and EBL, and successful confinement of PS spheres
within nanowell areas in nanohole arrays was noted.
The ability to efficiency trap and probe EVs in metallic NHAs was presented in
Chapter 4. Electron beam lithography was performed on a negative-tone resist, allowing
for fabrication of glass nanowells surrounded in metal. Functionalization of the NHA
with a well-known Raman reporter highlighted ideal sensing areas for SERS. Spatial
resolution was limited during mapping due to the 100 × (0.9 N.A.) objective, which
confined the laser beam to a 1 μm x 1 μm2 area on the NHA substrate. However, mapping
was successful in proving hot-spots lied within central glass nanowell cavities. This was
tested by detection of polystyrene spheres from below a metallic nanohole array. SERS
acquisition revealed expected spectra for polystyrene, demonstrating successful
confinement of nanomaterials to desired sensing areas.
Successful trapping of PS nanospheres and subsequent SERS acquisition lead to
probing of spectral signatures of EVs in Chapter 4. The structural characteristics of EVs
were first characterized by fluorescence and SEM, revealing isolated vesicles with intact
lipid membranes. NSL substrates were subsequently used to characterize the average
SERS response of a bulk EV sample (unsorted). The components of bulk EV samples
revealed contents with nucleic acids, lipids and proteins and displayed high similarity to
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the EV samples characterized previously in the literature.1, 10, 11 Metallic NHAs were then
used to sort and trap individual EVs and for acquisition of SERS spectra. Trapping within
nanowells was successful. SEM imaging revealed the ability of the NHA to capture more
than one EV per nanowell, which may be circumvented future work by use of antibodies
specific to EV membranes.
Probing of SERS spectra from EVs trapped within wells of a metallic NHA
revealed spectral characteristics similar to those acquired on NSL substrates. There
existed a diversity amongst EVs isolated from the same cell line, suggesting different
roles and release mechanisms for individual vesicles. Intensity differences amongst the
EV population from an individual cell line signaled increases in the quantity of specific
biomaterial components. The SERS spectra of EVs released from two cell lines, a
prostate cancer cell line and a mesenchymal stem cell line were also compared. The
presence of nucleic acids, as well as lipid and protein contents suggested conserved
biological functions, a finding previously reported in the literature.10 Conserved
biological functions such as lipid membranes for protection and encapsulation of
materials are essential for formation of EVs and were therefore expected to display
themselves in SERS spectra from both EV lines.
This thesis demonstrated successful fabrication of a nanohole-array based sensor
capable of probing molecular information from nanoscale biological materials. This
nanodevice holds high potential in point-of-care diagnostics for cancer or disease
detection.
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5.2 Outlook
Throughout this thesis, a nanoscale device was fabricated for trapping, sorting and
probing of nanoscale biological materials known as extracellular vesicles. The
nanodevice allowed for molecular-level characterization of biological vesicles isolated
from cultured cell lines by SERS. Future work may seek to combine nanohole arrays with
microfluidic technologies. If microfluidic channels are fabricated to sort and isolate
vesicles from other biological debris, flow through of EVs onto nanohole arrays could
allow for direct and rapid detection of EVs from human liquid biopsies. This would
extend the device to a point-of-care screening tool, whereby clinicians could better assess
and diagnose patients with less-invasive screening tools.
In line with incorporation of NHAs into a microfluidic device, previous literature
by Wang et al. highlights a method of isolating EVs from biological samples by
incorporation of microfluidics and nanofabrication.12 This group fabricated a nanodevice
containing ciliated micropillar structured forming a nanowire-on-micropillar trap for
selective capture of exosome-like vesicles (40 – 100 nm in diameter). Flow of EVs
through the device selectively trapped exosomes within nanowires, while proteins and
cell debris flowed through the device for removal (Figure 5.1). Exosomes were recovered
by flooding the device with phosphate-buffered saline (PBS), a buffer solution commonly
used during cell culture/EV isolation. In the future, a device incorporating nanowire-onmicropillar traps for initial isolation of EVs from complex biological samples, followed
with recovery of EVs in PBS and subsequent flow through of EVs onto a nanohole array
could allow for SERS-based detection of EVs from complex biological samples.
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Figure 5.1 - Exosomes trapped within “nanowire-on-micropillar” structures and
subsequently separated from cellular debris and proteins. Inlay shows (a)
Nanowires; (b) Micropillars; (c) “Nanowire-on-micropillar” structures. Reproduced
with permission.12
In this thesis, electron beam lithography (EBL) was presented as a means of
fabricating metallic nanohole arrays in a reproducible manner. Although EBL presents
many advantages over other lithographic techniques due to its high resolution and
reproducibility, fabrication of metallic nanohole arrays requires significant amounts of
time and requires advanced nanofabrication skills. Other methods of fabrication may be
explored in the future to minimize these limitations. In recent years, stencil lithography
has emerged as a great method for fabrication of nanohole arrays.13 Stencil lithography is
a resistless, scalable and high-throughput technique allowing for fabrication of
nanostructures over large surface-areas with a reusable mask. Nanostencil lithography
has also been presented on non-conventional lithographic substrates such as flexible
polymers14, 15 and PDMS-based microfluidic devices.13 Fabrication costs can largely be
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minimized by reuse of nanostencil masks. In addition, the mask may be fabricated to
cover the entire surface area of the substrate and requires less advanced training due to
non-use of resists and an electron beam source.
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